|
| A) | Centers for Disease Control and Prevention (CDC) | ||
| B) | Occupational Safety and Health Administration (OSHA) | ||
| C) | National Institute for Occupational Safety and Health | ||
| D) | Occupational Safety and Health Review Commission |
| A) | control plan. | ||
| B) | TB control plan. | ||
| C) | exposure control plan. | ||
| D) | None of the above |
| A) | 10,347 | ||
| B) | 136,520 | ||
| C) | 1.3 million | ||
| D) | 13 million |
| A) | certified by CDC/NIOSH. | ||
| B) | properly fitted to the wearer. | ||
| C) | a nonpowered particulate filter respirator or a powered air-purifying respirator. | ||
| D) | All of the above |
| A) | Application of sutures | ||
| B) | Administration of immunizations | ||
| C) | Physical therapy or chiropractic treatment | ||
| D) | All of the above |
| A) | 740 | ||
| B) | 1,250 | ||
| C) | 6,430 | ||
| D) | 9,500 |
| A) | OSHA Toxic and Hazardous Substances. | ||
| B) | American Conference of Governmental Industrial Hygienists. | ||
| C) | National Toxicology Program Annual Report on Carcinogens. | ||
| D) | All of the above |
| A) | sharps. | ||
| B) | genotoxic waste. | ||
| C) | infectious and anatomic waste. | ||
| D) | chemicals and pharmaceuticals. |
| A) | 10% | ||
| B) | 25% | ||
| C) | 40% | ||
| D) | 75% |
| A) | spill location. | ||
| B) | physical and hazardous properties of the material. | ||
| C) | quantity of the chemical or biologic substance released. | ||
| D) | All of the above |
| A) | weekly. | ||
| B) | monthly. | ||
| C) | quarterly. | ||
| D) | annually. |
| A) | sick air syndrome. | ||
| B) | sick building syndrome. | ||
| C) | indoor contamination syndrome. | ||
| D) | contaminated building syndrome. |
| A) | oxygen. | ||
| B) | iron oxide. | ||
| C) | nitrous oxide. | ||
| D) | All of the above |
| A) | prolonged, awkward working positions. | ||
| B) | recurrent heavy lifting, pushing, or pulling. | ||
| C) | tasks that require prolonged, repetitive movements. | ||
| D) | All of the above |
| A) | Anaphylaxis | ||
| B) | Allergic contact dermatitis | ||
| C) | Irritant contact dermatitis | ||
| D) | Hypersensitivity immune system response |
| A) | safety conditions. | ||
| B) | employee medical records. | ||
| C) | training and education records. | ||
| D) | All of the above |
| A) | 100 employees at one site. | ||
| B) | 250 employees at one site. | ||
| C) | 500 employees at one site. | ||
| D) | 750 employees at one site. |
| A) | "safety violation." | ||
| B) | "unsafe condition." | ||
| C) | "imminent danger." | ||
| D) | "identified hazard." |
| A) | right to privacy. | ||
| B) | employee rights. | ||
| C) | Fourth Amendment right. | ||
| D) | Fifth Amendment right. |
| A) | repeat. | ||
| B) | willful. | ||
| C) | serious. | ||
| D) | other than serious. |